PRICE T ROWE ASSOCIATES INC /MD/ - NUVATION BIO INC ownership

NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 121 filers reported holding NUVATION BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of NUVATION BIO INC
ValueSharesWeighting
Q3 2023$1,062
-26.8%
791,911
-1.7%
0.00%
Q2 2023$1,451
+2.2%
805,819
-5.7%
0.00%
Q1 2023$1,420
-15.4%
854,667
-2.3%
0.00%
Q4 2022$1,679
-99.9%
874,837
-4.0%
0.00%
Q3 2022$2,043,000
+640.2%
911,533
+971.0%
0.00%
Q2 2022$276,000
+4.2%
85,107
+68.7%
0.00%
Q1 2022$265,000
-16.4%
50,454
+35.5%
0.00%
Q4 2021$317,000
+126.4%
37,242
+164.6%
0.00%
Q3 2021$140,000
+30.8%
14,076
+22.6%
0.00%
Q2 2021$107,00011,4830.00%
Other shareholders
NUVATION BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Omega Fund Management, LLC 22,957,340$120,756,00024.71%
Aisling Capital Management LP 2,541,009$13,366,0007.21%
EDBI Pte Ltd 1,270,504$6,683,0004.45%
Ally Bridge Group (NY) LLC 1,137,152$5,981,0004.43%
EcoR1 Capital, LLC 13,896,543$73,096,0002.29%
Boxer Capital, LLC 4,341,009$22,834,0001.17%
Baupost Group 10,443,494$54,933,0000.59%
Redmile Group, LLC 3,471,709$18,261,0000.57%
Avidity Partners Management LP 4,855,006$25,537,0000.53%
Abrams Capital Management 3,811,513$20,049,0000.47%
View complete list of NUVATION BIO INC shareholders